103 related articles for article (PubMed ID: 1801587)
1. Potassium channel activators in vascular smooth muscle.
Cox RH
Adv Exp Med Biol; 1991; 308():27-43. PubMed ID: 1801587
[No Abstract] [Full Text] [Related]
2. K(+)-channel activators in vascular smooth muscle.
Cox RH
Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
[No Abstract] [Full Text] [Related]
3. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
Kitamura K; Ogata R
Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
[No Abstract] [Full Text] [Related]
4. A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim.
Gelband CH; Lodge NJ; Van Breemen C
Eur J Pharmacol; 1989 Aug; 167(2):201-10. PubMed ID: 2591475
[TBL] [Abstract][Full Text] [Related]
5. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
Zhang H; Stockbridge N; Weir B
Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488
[No Abstract] [Full Text] [Related]
6. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
7. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
Stockbridge N; Zhang H; Weir B
Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
[TBL] [Abstract][Full Text] [Related]
8. Effect of BRL 38227 on K-currents in rat portal vein.
Edwards G; Noack T; Deitmer P; Weston AH
Jpn J Pharmacol; 1992; 58 Suppl 2():336P. PubMed ID: 1507585
[No Abstract] [Full Text] [Related]
9. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
McPherson GA; Angus JA
Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery.
Plane F; Garland CJ
Br J Pharmacol; 1993 Oct; 110(2):651-6. PubMed ID: 8242238
[TBL] [Abstract][Full Text] [Related]
11. Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivo.
Toombs CF; Norman NR; Groppi VE; Lee KS; Gadwood RC; Shebuski RJ
J Pharmacol Exp Ther; 1992 Dec; 263(3):1261-8. PubMed ID: 1469632
[TBL] [Abstract][Full Text] [Related]
12. Effects of potassium channel toxins from Leiurus quinquestriatus hebraeus venom on responses to cromakalim in rabbit blood vessels.
Strong PN; Weir SW; Beech DJ; Hiestand P; Kocher HP
Br J Pharmacol; 1989 Nov; 98(3):817-26. PubMed ID: 2531622
[TBL] [Abstract][Full Text] [Related]
13. Hyperpolarizing action of cromakalim on the rat aorta.
Doggrell SA; Smith JW; Downing OA; qilson KA
Eur J Pharmacol; 1989 Dec; 174(1):131-3. PubMed ID: 2612577
[TBL] [Abstract][Full Text] [Related]
14. Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein.
Beech DJ; Bolton TB
Br J Pharmacol; 1989 Nov; 98(3):851-64. PubMed ID: 2590772
[TBL] [Abstract][Full Text] [Related]
15. Potassium channel blockers and the effects of cromakalim on the smooth muscle of the guinea-pig bladder.
Fujii K; Foster CD; Brading AF; Parekh AB
Br J Pharmacol; 1990 Apr; 99(4):779-85. PubMed ID: 2361173
[TBL] [Abstract][Full Text] [Related]
16. [Potassium agonists].
Hellwig B
Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166
[No Abstract] [Full Text] [Related]
17. Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
Schilling L; Parsons AA; Wahl M
J Neurosurg; 1995 Jul; 83(1):123-8. PubMed ID: 7782827
[TBL] [Abstract][Full Text] [Related]
18. Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim.
McPherson GA; Angus JA
Br J Pharmacol; 1989 Jul; 97(3):941-9. PubMed ID: 2758244
[TBL] [Abstract][Full Text] [Related]
19. Evidence that acetylcholine-mediated hyperpolarization of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim.
McPherson GA; Angus JA
Br J Pharmacol; 1991 May; 103(1):1184-90. PubMed ID: 1908733
[TBL] [Abstract][Full Text] [Related]
20. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
Longman SD; Clapham JC; Wilson C; Hamilton TC
J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
